Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank89
3Y CAGR-3.1%
5Y CAGR+24.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-3.1%/yr
vs +27.8%/yr prior
5Y CAGR
+24.2%/yr
Recent deceleration
Acceleration
-30.9pp
Decelerating
Percentile
P89
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $111.04M | +55.0% |
| 2024 | $71.62M | +6.2% |
| 2023 | $67.45M | -44.7% |
| 2022 | $121.97M | +81.3% |
| 2021 | $67.27M | +78.9% |
| 2020 | $37.60M | +92.6% |
| 2019 | $19.52M | -57.3% |
| 2018 | $45.72M | +8.7% |
| 2017 | $42.05M | +30.3% |
| 2016 | $32.27M | - |